Data About Zetia Risks Was Not Fully Revealed
36441
New evidence shows that drug makers Merck and Schering-Plough never published several studies that raised questions about a cholesterol drugâs risks to the liver.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
606892
NEW YORK -- Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its website yesterday, citing internal documents from the drug maker and e-mail messages of its managers.
498994
The maker of the controversial diabetes pill Avandia on Tuesday published preliminary results of a study that the company claims show the drug does not raise heart risks. However, experts say the results are inconclusive and even seem to suggest more risk from the drug.
336778
U.S. FDA staff reviewers on Tuesday  said data on a new non-Hodgkin's lymphoma drug made by Inex  Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc. may be  unreliable due to the trial's structure and size.
375264
Numbers don't lie &#151; or do they? When it comes to public health, figures are seldom straightforward.
142813
A major new study out Monday found that a cholesterol-lowering drug pulled from the US market in 2001 had a substantially higher risk of a serious side effect than three top-selling competitors.
203886
The maker of the controversial diabetes pill Avandia pointed to early results of its own study Tuesday, saying they offered reassuring evidence the drug doesn't raise heart risks. However, outside experts called the results inconclusive at best and a sign of greater risk at worst.
761256
The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress...
33756
Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements after a failed study generated negative publicity.
673521
The FDA probably will not approve a patch for women suffering from hypoactive sexual desire disorder, as an advisory board believes more evidence is needed to prove the drug is safe. By Kristen Philipkoski.
625730
The first drug to treat female sexual dysfunction isn&#39;t ready for the market yet because of safety concerns, a federal advisory committee cautioned Thursday.
300657
Two new studies are offering mixed  signals about the long-term safety of repeatedly giving  pregnant women steroid drugs intended to prevent complications  once a premature delivery seems likely.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.
142265
-- The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on the market eight years ago, a leading member of Congress...
32212
Some researchers in a study said they found Aleve could increase the risk of heart attacks or strokes. But others say the results are not conclusive.
182075
AstraZeneca Plc. said on Wednesday a new study in Japan showed a higher rate of a potentially fatal side effect in patients taking its lung cancer pill Iressa than that demonstrated in an earlier analysis.